Ultrasound-Guided Nerve Block for Hip Fractures
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method for managing hip fracture pain in the emergency room. Researchers aim to determine if an ultrasound-guided nerve block using bupivacaine (a local anesthetic) is as effective as the usual pain treatment with IV morphine. Participants will receive either the ultrasound-guided nerve block or the standard morphine treatment. Suitable candidates for this study include individuals with a confirmed hip fracture experiencing moderate to severe pain. As an unphased trial, this study allows participants to contribute to innovative pain management research that could enhance emergency care practices.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude those who have used certain blood thinners like NOACs within 48 hours or LMWH within specific time frames before the procedure.
What prior data suggests that this ultrasound-guided femoral nerve block is safe for hip fracture patients?
Research has shown that using ultrasound to guide femoral nerve blocks is generally safe. A large study found complications in only 0.4% of over 2,700 procedures across various emergency rooms. This equates to only 4 out of every 1,000 patients experiencing issues, with just one major problem reported. Other studies indicate that this method effectively manages pain, especially compared to opioids. Overall, evidence suggests that patients tolerate this treatment well.12345
Why are researchers excited about this trial?
Researchers are excited about the ultrasound-guided femoral nerve block for hip fractures because it offers a new method of delivering pain relief. Unlike traditional methods that rely solely on intravenous morphine, this approach uses ultrasound to precisely guide the nerve block, potentially leading to more effective pain management and fewer side effects. Bupivacaine, the active ingredient in the nerve block, provides targeted analgesia directly at the source of pain, which could mean faster relief and improved patient comfort. This technique might reduce the need for systemic pain medications, which often come with a host of side effects. By refining the way pain is managed in hip fractures, this method could revolutionize patient care and recovery.
What evidence suggests that this trial's treatments could be effective for hip fractures?
Research has shown that using ultrasound to guide a femoral nerve block can relieve pain from hip fractures more effectively than regular pain medications. In this trial, some participants will receive an ultrasound-guided femoral nerve block with analgesia using 0.5% bupivacaine. Studies have found that this method not only reduces pain but also improves mobility after a hip fracture. The technique uses ultrasound to help doctors precisely target the nerve, enhancing pain relief. Early results suggest that patients experience less pain and may require fewer strong painkillers, such as opioids, with this method. Overall, the ultrasound-guided femoral nerve block appears promising for reducing pain during hip fracture recovery.12467
Who Is on the Research Team?
Beatrice Hoffmann, MD PhD
Principal Investigator
Beth Israel Deaconess Medical
Are You a Good Fit for This Trial?
This trial is for adults over 18 who come to the emergency department with a confirmed hip fracture and have moderate to severe pain. They must be able to give consent and participate in the study.Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Ultrasound Guided Femoral Nerve Blockade or standard parenteral opioid pain management
Follow-up
Participants are monitored for pain intensity reduction and side effects using Visual Analog Scale (VAS)
What Are the Treatments Tested in This Trial?
Interventions
- Bupivacaine
- Morphine
- Ultrasound Guided Femoral Nerve Blockade
Bupivacaine is already approved in United States, European Union, Canada for the following indications:
- Local anesthesia for surgery
- Acute pain management
- Spinal anesthesia
- Local anesthesia for surgery
- Acute pain management
- Spinal anesthesia
- Local anesthesia for surgery
- Acute pain management
- Spinal anesthesia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Beth Israel Deaconess Medical Center
Lead Sponsor